OLAPARIB vs TALAZOPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OLAPARIB vs TALAZOPARIB: Safety Overview
| Metric | OLAPARIB | TALAZOPARIB |
|---|---|---|
| Total FAERS Reports | 18,274 | 1,477 |
| Deaths Reported | 5,496 | 278 |
| Death Rate | 30.1% | 18.8% |
| Hospitalizations | 3,471 | 553 |
| Average Patient Age | 62.3 yrs | 60.1 yrs |
| % Female Patients | 79.9% | 55.7% |
| FDA Approval Date | Aug 17, 2017 | Jun 20, 2023 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Discontinued |